Salah E Aref

Summary

Publications

  1. Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology. 2012;17:118-21 pubmed publisher
    ..804, P = 0.000; IgG: r - 0.907, P = 0.000; IgM: r - 0.467, P = 0.002; and IgA: r - 0.519, P = 0.000). Autoimmune mechanism plays an important role in the HCV-associated thrombocytopenia and spleen is a major source of PAIgs. ..
  2. Aref S, El Ghonemy M, Abouzeid T, El Sabbagh A, El Baiomy M. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients. Leuk Res. 2014;38:722-5 pubmed publisher
    ..In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML. ..
  3. request reprint
    Aref S, el Sherbiny M, Mabed M, Menessy A, El Refaei M. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion. Hematology. 2003;8:385-91 pubmed
    ..001 for all). In conclusion, MMP-9 and su PAR levels might be used as a marker for disease activity and may contribute to blast cell dissemination. MMP-9 and suPAR may be target molecules in the strategy of treatment of AML. ..
  4. request reprint
    Aref S, Salama O, Al Tonbary Y, Mansour A. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Hematology. 2004;9:113-21 pubmed
    ....

Detail Information

Publications4

  1. Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology. 2012;17:118-21 pubmed publisher
    ..804, P = 0.000; IgG: r - 0.907, P = 0.000; IgM: r - 0.467, P = 0.002; and IgA: r - 0.519, P = 0.000). Autoimmune mechanism plays an important role in the HCV-associated thrombocytopenia and spleen is a major source of PAIgs. ..
  2. Aref S, El Ghonemy M, Abouzeid T, El Sabbagh A, El Baiomy M. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients. Leuk Res. 2014;38:722-5 pubmed publisher
    ..In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML. ..
  3. request reprint
    Aref S, el Sherbiny M, Mabed M, Menessy A, El Refaei M. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion. Hematology. 2003;8:385-91 pubmed
    ..001 for all). In conclusion, MMP-9 and su PAR levels might be used as a marker for disease activity and may contribute to blast cell dissemination. MMP-9 and suPAR may be target molecules in the strategy of treatment of AML. ..
  4. request reprint
    Aref S, Salama O, Al Tonbary Y, Mansour A. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Hematology. 2004;9:113-21 pubmed
    ....